Literature DB >> 19787565

[Ambulatory aftercare of forensic patients after release].

Susanne Stübner1, Norbert Nedopil.   

Abstract

OBJECTIVE: The efficacy of specific forensic outpatient treatment should be investigated.
METHODS: In 2000 the Ministry of Social Affairs of the State of Bavaria, Germany, implemented a model for forensic outpatient treatment. Three forensic hospitals established forensic outpatient clinics. The Department of Forensic Psychiatry of the Psychiatric Hospital of the Ludwig Maximilian University of Munich evaluated the treatment and management programs with financial support from the Ministry.
RESULTS: 111 mentally ill offenders were included after release from forensic hospitals. 65 % suffered from schizophrenia. In 4.5 years time of observation a recidivism rate of 0.9 % of severe offences could be found (3.6 % including cases of suspicion). 17 % of the patients needed a rehospitalisation and 12 % a legal intervention. At the end of the observation period 42 patients still needed treatment, but 44 patients continued therapy in the forensic outpatient setting out of own interests.
CONCLUSIONS: In accordance to literature very low rates of criminal recidivism under specific forensic outpatient aftercare could be found, and in addition a relatively high compliance with the treatment. Georg Thieme Verlag KG Stuttgart. New York.

Entities:  

Mesh:

Year:  2009        PMID: 19787565     DOI: 10.1055/s-0029-1223336

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  2 in total

1.  [Effectiveness of aftercare treatment after release from prison: A first evaluation of the forensic therapeutic outpatient clinic for serious violent and sexual offenders in Berlin].

Authors:  J Sauter; T Voss; K-P Dahle
Journal:  Nervenarzt       Date:  2015-05       Impact factor: 1.214

2.  [Evaluation of outpatient aftercare of forensic patients (§ 63 StGB) in North Rhine-Westphalia, Germany].

Authors:  F Schmidt-Quernheim; D Seifert
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.